Literature DB >> 24074660

The use of spinal angiography in the management of posterior mediastinal tumors: case series and review of the literature.

Andrew B Nordin1, Sara C Fallon, Andrew Jea, Eugene S Kim.   

Abstract

INTRODUCTION: Resection of inferiorly located posterior mediastinal tumors can be complicated by their proximity to the artery of Adamkiewicz (AKA). Although uncommon, intraoperative injury to the AKA may result in paraparesis or paralysis secondary to spinal cord ischemia. The use of preoperative spinal angiography may serve as a useful adjunct to the surgeon in guiding extent of resection of the tumor to avoid injury to this critical artery.
METHODS: After IRB approval (H-31712), three patients, from 2008 to 2011, with lower posterior mediastinal tumors were identified. Their charts were reviewed for information concerning preoperative imaging, operative details, and postoperative neurologic complications. The literature regarding imaging of the AKA, cases of injury in pediatric patients, and recommendations for treatment after its injury were reviewed.
RESULTS: One patient, who did not have preoperative spinal angiography, developed transient paresis lasting 6 weeks after posterior mediastinal tumor resection. Two patients underwent preoperative spinal angiography with successful localization of the AKA. In both cases, the patients subsequently underwent posterior mediastinal tumor resection without injury to the artery and without postoperative neurologic sequelae.
CONCLUSIONS: Preoperative spinal angiography may serve as a useful adjunct in the evaluation of children with inferior posterior mediastinal tumors in order to delineate the relationship of the artery of Adamkiewicz to the tumor for the purpose of guiding surgical resection.
© 2013.

Entities:  

Keywords:  Adamkiewicz; Angiography; Lipoblastoma; Mediastinal; Neuroblastoma

Mesh:

Year:  2013        PMID: 24074660     DOI: 10.1016/j.jpedsurg.2013.04.029

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  7 in total

1.  The role of spinal angiography in the evaluation and treatment of pediatric spinal vascular pathology: a case series and systematic review.

Authors:  Eric Goethe; Melissa A LoPresti; Peter Kan; Sandi K Lam
Journal:  Childs Nerv Syst       Date:  2019-08-14       Impact factor: 1.475

2.  Preoperative spinal angiography decreases risk of spinal ischemia in pediatric posterior thoracic tumor resection.

Authors:  Rachael A Clark; Jillian C Jacobson; Joseph T Murphy
Journal:  Pediatr Surg Int       Date:  2022-07-22       Impact factor: 2.003

3.  International Society of Paediatric Surgical Oncology (IPSO) Surgical Practice Guidelines.

Authors:  Simone de Campos Vieira Abib; Chan Hon Chui; Sharon Cox; Abdelhafeez H Abdelhafeez; Israel Fernandez-Pineda; Ahmed Elgendy; Jonathan Karpelowsky; Pablo Lobos; Marc Wijnen; Jörg Fuchs; Andrea Hayes; Justin T Gerstle
Journal:  Ecancermedicalscience       Date:  2022-02-17

4.  Robot-assisted thoracoscopic resection of a posterior mediastinal tumor with preserving the artery of Adamkiewicz.

Authors:  Yukiko Nemoto; Koji Kuroda; Masataka Mori; Masatoshi Kanayama; Tiaji Kuwata; Masaru Takenaka; Fumihiro Tanaka
Journal:  Surg Case Rep       Date:  2022-07-06

Review 5.  Mesenchymal tumours of the mediastinum--part I.

Authors:  Michael A den Bakker; Alexander Marx; Kiyoshi Mukai; Philipp Ströbel
Journal:  Virchows Arch       Date:  2015-09-10       Impact factor: 4.064

6.  Extragonadal germ cell tumor of the posterior mediastinum in a child complicated with spinal cord compression: a case report.

Authors:  Dong Keon Yon; Tae Keun Ahn; Dong Eun Shin; Gwang Il Kim; Moon Kyu Kim
Journal:  BMC Pediatr       Date:  2018-03-05       Impact factor: 2.125

7.  The Relevance of Preoperative Identification of the Adamkiewicz Artery in Posterior Mediastinal Pediatric Tumors.

Authors:  Andreas Schmidt; Johann-Martin Hempel; Verena Ellerkamp; Steven W Warmann; Ulrike Ernemann; Jörg Fuchs
Journal:  Ann Surg Oncol       Date:  2021-07-31       Impact factor: 5.344

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.